Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
291,1 GBX | -1,32 % | -9,88 % | -17,42 % |
Resumen de negocios
Número de empleados: 143
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cell Therapy
55,3
%
| 31 | 69,0 % | 23 | 55,3 % | -25,26 % |
Program-related
27,8
%
| 5 | 10,4 % | 11 | 27,8 % | +148,38 % |
Drug Discovery
16,9
%
| 9 | 20,6 % | 7 | 16,9 % | -23,14 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 44 | 100,0 % | 41 | 100,0 % | -6,72 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Maher Masoud
CEO | Chief Executive Officer | 49 | - |
Douglas Swirsky
DFI | Director of Finance/CFO | 54 | 27/03/23 |
James Brady
CTO | Chief Tech/Sci/R&D Officer | - | - |
Ron Holtz
ADM | Chief Administrative Officer | 66 | 01/01/05 |
Corporate Officer/Principal | - | 21/08/23 | |
Gene Zhu
LAW | General Counsel | - | - |
Jill Mayer
HRO | Human Resources Officer | - | 01/01/18 |
Thomas Ross
SAM | Sales & Marketing | 63 | 15/10/14 |
Steven Nardi
PRN | Corporate Officer/Principal | - | 13/10/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Patrick Balthrop
BRD | Director/Board Member | 67 | 01/12/22 |
Art Mandell
BRD | Director/Board Member | 71 | 01/05/06 |
Will Brooke
BRD | Director/Board Member | 68 | 01/03/04 |
Stanley Erck
BRD | Director/Board Member | 76 | 01/01/05 |
Ron Holtz
ADM | Chief Administrative Officer | 66 | 01/01/05 |
John Johnston
BRD | Director/Board Member | 65 | 01/01/16 |
Richard Douglas
CHM | Chairman | 71 | 12/02/18 |
Yasir Al-Wakeel
BRD | Director/Board Member | 42 | 15/06/21 |
Rekha Hemrajani
BRD | Director/Board Member | 54 | 15/06/21 |
Maher Masoud
CEO | Chief Executive Officer | 49 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 104 128 650 | 97 898 738 ( 94,02 %) | 0 | 94,02 % |
Información de la empresa
Sector
Ventas por actividad
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-17,42 % | 386 M | |
+7,89 % | 217 mil M | |
+6,74 % | 183 mil M | |
+9,85 % | 131 mil M | |
+23,99 % | 106 mil M | |
-0,95 % | 62,16 mil M | |
+11,29 % | 51,02 mil M | |
+4,81 % | 50,89 mil M | |
-0,64 % | 40,16 mil M | |
+0,21 % | 34,79 mil M |
- Bolsa de valores
- Acciones
- Acción MXCT
- Empresa MaxCyte, Inc.